Bank Of America Corp T2 Biosystems, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.09 - $565.0 $148 - $931,685	-1,649 Reduced 13.04%	11,000 $1,000
Q2 2022 Aug 12, 2022	SELL	$0.15 - $0.54 $247 - $890	-1,649 Reduced 11.53%	12,649 $2,000
Q1 2022 May 16, 2022	SELL	$0.36 - $0.57 $190 - $301	-529 Reduced 3.57%	14,298 $8,000
Q4 2021 Feb 08, 2022	BUY	$0.46 - $0.94 $1,691 - $3,456	3,677 Added 32.98%	14,827 $7,000
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $245 - $344	-285 Reduced 2.49%	11,150 $10,000
Q2 2021 Sep 13, 2021	BUY	$1.04 - $1.69 $11,892 - $19,325	11,435 New	11,435 $14,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.